These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 808560

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE, Nordby JM, Milstein H.
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [Abstract] [Full Text] [Related]

  • 23. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L, Capin R, Capin NR, Sepúlveda B, Zamacona G.
    Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
    [Abstract] [Full Text] [Related]

  • 24. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB, Kolb WP, Olson MS.
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunological studies of human placentae: complement components in immature and mature chorionic villi.
    Faulk WP, Jarret R, Keane M, Johnson PM, Boackle RJ.
    Clin Exp Immunol; 1980 May; 40(2):299-305. PubMed ID: 7002386
    [Abstract] [Full Text] [Related]

  • 27. Testing of hemolytic complement components in domestic animals.
    Barta O, Hubbert NL.
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [Abstract] [Full Text] [Related]

  • 28. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP, Simons RL, Douglas RG.
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [Abstract] [Full Text] [Related]

  • 29. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
    Ji YH, Matsushita M, Okada H, Fujita T, Kawakami M.
    J Immunol; 1988 Dec 15; 141(12):4271-5. PubMed ID: 3058802
    [Abstract] [Full Text] [Related]

  • 30. Humoral immunostimulation. IV. Role of complement.
    Shearer WT, Atkinson JP, Frank MM, Parker CW.
    J Exp Med; 1975 Apr 01; 141(4):736-52. PubMed ID: 1168690
    [Abstract] [Full Text] [Related]

  • 31. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A, Bozzoli C, Puddu GM, Sangiorgi Z, Dormi A, Rovinetti C, Descovich GC, Puddu P.
    Am J Med; 1995 Apr 01; 98(4):357-64. PubMed ID: 7709948
    [Abstract] [Full Text] [Related]

  • 32. [Complement system proteins in the acute phase of myocardial infarction].
    Gukasian IA, Kovanov VV, Khil'kin AM, Shmelev IA.
    Vopr Med Khim; 1980 Apr 01; 26(3):362-5. PubMed ID: 7456367
    [Abstract] [Full Text] [Related]

  • 33. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1871-6. PubMed ID: 3029223
    [Abstract] [Full Text] [Related]

  • 34. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M, Marggraf G, Neuhäuser M, Forkel J, Herold U, Kamler M, Massoudy P, Jakob H.
    Eur J Cardiothorac Surg; 2006 Aug 15; 30(2):285-93. PubMed ID: 16829095
    [Abstract] [Full Text] [Related]

  • 35. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL, Sloan LB, Oglesby TJ, Farries TC, Nickells MW, Densen P, Harley JB, Atkinson JP.
    J Immunol; 1989 Oct 01; 143(7):2256-61. PubMed ID: 2506280
    [Abstract] [Full Text] [Related]

  • 36. Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with sepharose derivatives on the anticoagulant.
    Nakanishi K, Zbar B, Borsos T.
    Cancer Res; 1985 Sep 01; 45(9):4122-7. PubMed ID: 3928150
    [Abstract] [Full Text] [Related]

  • 37. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov 01; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 38. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC.
    J Immunol; 1982 Jul 01; 129(1):168-72. PubMed ID: 6979566
    [Abstract] [Full Text] [Related]

  • 39. Complement deposition in glomerular diseases.
    di Belgiojoso GB, Tarantino A, Durante A, Guerra L.
    Proc Eur Dial Transplant Assoc; 1975 Jul 01; 11():515-21. PubMed ID: 1105561
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.